Nevanac FDA Approval History
FDA Approved: Yes (First approved August 19, 2005)
Brand name: Nevanac
Generic name: nepafenac
Dosage form: Ophthalmic Suspension
Company: Alcon, Inc.
Treatment for: Postoperative Ocular Inflammation
Nevanac (nepafenac) is a topical nonsteroidal anti-inflammatory (NSAID) and analgesic prodrug indicated for the treatment of pain and inflammation associated with cataract surgery.
Development timeline for Nevanac
| Date | Article |
|---|---|
| Aug 19, 2005 | Approval Nevanac Alcon, Inc. - Treatment for Pain and Inflammation Associated with Cataract Surgery |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
